OMI's image-guided workstation cleared by FDA:
This article was originally published in Clinica
OMI (US) has received 510(k) clearance from the US FDA to market its Mayfield/Acciss image-guided stereotactic workstation for brain surgery in the US. The system uses a directional operational arm to identify the border of abnormalities in the brain, such as tumours. The Cincinnati, Ohio-based company says the workstation could also be used for orthopaedic and spinal surgery in the future.
You may also be interested in...
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.
The AAM has insisted that the US Supreme Court should uphold the inter partes review framework, in an amicus brief filed as part of litigation that potentially threatens hundreds of IPR decisions.